Moreover, Tat-BECN1 treatment decreased the protein level of cyclin D1 in HMGB1-depleted CRC cells, whereas Tat had no significant effect on CDK6 expression (Supplementary Figure S5B). This evidence concerns the gene CDK6 and colorectal carcinoma.